{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["5(4)"],"submitter":["Stetson RC"],"pubmed_abstract":["<h4>Introduction</h4>Infants in neonatal intensive care units require painful and noxious stimuli as part of their care. Judicious use of analgesic medications, including opioids, is necessary. However, these medications have long- and short-term side effects, including potential neurotoxicity. This quality improvement project's primary aim was to decrease opioid exposure by 33% in the first 14 days of life for infants less than 1,250 g at birth within 12 months.<h4>Methods</h4>A multidisciplinary care team used <i>Define, Measure, Analyze, Improve, Control</i> methodology to identify root causes of the quality gap including: (1) inconsistent reporting of objective pain scales; (2) variable provider prescribing patterns; and (3) variable provider bedside assessment of pain. These root caus"],"journal":["Pediatric quality & safety"],"pagination":["e312"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7339154"],"repository":["biostudies-literature"],"pubmed_title":["Reducing Opioid Exposure in a Level IV Neonatal Intensive Care Unit."],"pmcid":["PMC7339154"],"pubmed_authors":["Smith BN","Ferrie LJ","Schuh AR","Brumbaugh JE","Schuning VS","Stetson RC","Misgen MA","Fang JL","Sanders NL"],"additional_accession":[]},"is_claimable":false,"name":"Reducing Opioid Exposure in a Level IV Neonatal Intensive Care Unit.","description":"<h4>Introduction</h4>Infants in neonatal intensive care units require painful and noxious stimuli as part of their care. Judicious use of analgesic medications, including opioids, is necessary. However, these medications have long- and short-term side effects, including potential neurotoxicity. This quality improvement project's primary aim was to decrease opioid exposure by 33% in the first 14 days of life for infants less than 1,250 g at birth within 12 months.<h4>Methods</h4>A multidisciplinary care team used <i>Define, Measure, Analyze, Improve, Control</i> methodology to identify root causes of the quality gap including: (1) inconsistent reporting of objective pain scales; (2) variable provider prescribing patterns; and (3) variable provider bedside assessment of pain. These root caus","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Jul-Aug","modification":"2025-04-19T01:00:32.371Z","creation":"2025-04-07T11:57:05.429Z"},"accession":"S-EPMC7339154","cross_references":{"pubmed":["32766487"],"doi":["10.1097/pq9.0000000000000312"]}}